HomeLUPIN • NSE
add
Lupin Ltd
Previous close
₹2,301.90
Day range
₹2,261.30 - ₹2,322.40
Year range
₹1,795.20 - ₹2,331.80
Market cap
1.06T INR
Avg Volume
806.05K
P/E ratio
21.33
Dividend yield
0.52%
Primary exchange
NSE
In the news
Financials
Income Statement
Revenue
Net income
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 71.68B | 24.27% |
Operating expense | 33.93B | 18.38% |
Net income | 11.76B | 37.47% |
Net profit margin | 16.40 | 10.59% |
Earnings per share | 32.18 | 72.18% |
EBITDA | 21.20B | 52.17% |
Effective tax rate | 22.44% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 62.82B | 115.71% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 197.28B | — |
Shares outstanding | 456.70M | — |
Price to book | 5.35 | — |
Return on assets | — | — |
Return on capital | 18.27% | — |
Cash Flow
Net change in cash
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 11.76B | 37.47% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is primarily a manufacturer of generic drugs, covering therapeutic areas such as paediatrics, cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis. Wikipedia
Founded
1968
Headquarters
Website
Employees
24,006
